DiaMedica shareholders approve 3M share increase to 2019 Omnibus Incentive Plan

DiaMedica Therapeutics Inc.

Shareholders approved amendment to increase shares available under 2019 Omnibus Incentive Plan by 3,000,000 shares.
All seven director nominees elected with >13.5M votes each; broker non-votes of ~11.77M.
Baker Tilly US, LLP appointed as independent auditor for FY2024 with 24.97M votes for.
Advisory vote on executive compensation passed (13.18M for); shareholders prefer one-year say-on-pay frequency.
67.9% of outstanding shares (25.77M of 37.96M) voted at the annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.